Abstract
More than 50% of human tumours carry mutations in TP53, so strategies to restore the activity of this tumour suppressor in cancer cells are being actively investigated by drug companies. A team of researchers in Sweden and Russia now report the discovery of a compound that reactivates p53 function and induces apoptosis in human cancer cells.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for freeCite
CITATION STYLE
APA
Novak, K. (2002). p53 restoration. Nature Reviews Cancer, 2(3), 159–159. https://doi.org/10.1038/nrc771
Readers' Seniority
Readers' Discipline
